If you need more lookups,
subscriptions start at $34 USD/month.
Ming Lei Location
United States
Ming Lei Work
CEO @ (December 2015 - Present)
Sr. Principal Biomedical Engineer @ Haemonetics, THE Blood Management Company (January 2013 - November 2015)
Staff Scientist and Group Leader @ 454 Life Sciences/Roche Diagnostics (January 2002 - January 2012)
Sr. Microfluidic Engineer and Group Leader @ BioMicro Systems (acquired by Roche NimbleGen) (January 2001 - January 2002)
Sr. Microfluidic Engineer and Group Leader @ BioMicro Systems (January 2001 - January 2002)
Sr. Engineer @ (November 1997 - July 2001)
Ming Lei Education
The Johns Hopkins University School of Medicine
(Biomedical Engineering)
1996-1997
North Carolina State University
Doctor of Philosophy (Biomedical Engineering)
1991-1996
Industrial Design Tu/E
(Engineering)
1990-1991
Sichuan University
Bachelor of Science
Ming Lei Skills
Biotechnology
Lifesciences
Microfluidics
DNA sequencing
Sequencing
Genomics
Molecular Biology
R&D
PCR
Biomedical Engineering
Medical Devices
Experimentation
Laboratory
Assay Development
DNA
Ming Lei Summary
Ming Lei, based in United States, is currently a CEO at Universal Sequencing Technology. Ming Lei brings experience from previous roles at Haemonetics, THE Blood Management Company, 454 Life Sciences/Roche Diagnostics, BioMicro Systems (acquired by Roche NimbleGen) and BioMicro Systems. Ming Lei holds a 1996 - 1997 The Johns Hopkins University School of Medicine. With a robust skill set that includes Biotechnology, Lifesciences, Microfluidics, DNA sequencing, Sequencing and more. Ming Lei has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Ming Lei?
Find contact details for 700 million professionals.